Therefore, the most important factor must be synergy between the two companies, which can only be created when there is a convergent focus. / share.". More so, the firm is considering a buyback program after the biosimilars asset sale. Viatris Inc. Please. Viatris began normal trading on November 16, 2020. Free cash flow remains strong to support shareholder returns and reinvestments. endstream endobj startxref Viatris began normal trading on November 16, 2020. If you have questions please email us or call us at 1-888-802-2747. 416.355.6346 As a helpful service to our shareholders, Pfizer Inc. is making available the NetBasis Cost Basis system via a hyperlink on our Web site. hbbd``b`a'= "c q=@*X V5UbX " rA,!Pb b8R* %@@HX 4qqn d Valheim . adjusted cost basis and Quicken will calculate the price/share. Date of distribution of spinoff (mm/dd/yyyy), 4. site in my original post Quicken computes the price/share at $11.64. ', does your calculation take into account that the spinoff ratio was Partnership tax returns have specific areas to reconcile these usually small differences. I/we have a beneficial long position in the shares of VTRS either through stock ownership, options, or other derivatives. The two risks that are important to keep an eye on are the high level of debt and a possible decrease in free cash flow. Tagged: Investments Welcome! By selecting the NetBasis link below, you will leave the Pfizer Inc. 3. If you need to save time and taxes, get a Netbasis full comprehensive cost basis report. Receive a unique team-based approach for your life, your family, your business. 346 0 obj <>stream All rights reserved. Netbasis has your securitys corporate actions (splits, mergers, spin-off, etc), pricing and dividend information. ICLUBcentral tax printer software automatically fills in these adjustments in the normal operation of the software using the data imported from your accounting records and that you enter from your 1099, Go to Transactions > Spinoff or Accounting > Securities > Record spinoff of securities depending on the version of the software being used. Corporate Securities Spinoff action that is no longer in the software. any other corporate action. I am not receiving compensation for it (other than from Seeking Alpha). The ability to optimize your tax strategy by selecting from a variety of sale methods. Therefore, Viatris might be a great example as there are many things to like. This publication and all the information, opinions and conclusions contained herein are protected by copyright. Here are some of our shareholder clients: Netbasis contains all of the pricing and dividend history including all splits, mergers and any other corporate action. Search within r/benzodiazepines. A decrease in free cash flow could sink Viatris's stock deeper down. As an example, institutional investors of large cap funds sold shares of Viatris, as they were obligated to sell their shares since Viatris is a mid cap stock. Finally, a buyback program can boost the stock price into a positive momentum environment. The dividend yield and the undervaluation are too attractive to ignore. To ensure this doesnt happen in the future, please enable Javascript and cookies in your browser. The cost basis allocation is dependent on the prices used for both Pfizer and Viatris in the cost basis allocation calculations. hb```b``na`c``eg@ ~(GZ"o``fHRuVI+`b , -@H+&X$A!A`#7%?XV0*06'0J13p` fzq C.e lf038H|0p56jGNd`3XA" ' 13+*/lc_$x ; Then for each old lot of Pfizer you'd do two Add actions, one for Pfizer at its reduced basis and one for Viatris. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments. Viatris began normal trading on November 16, 2020. This webcast may contain forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on these opportunities; manufacturing and product supply; our efforts to respond to COVID-19, including the Pfizer-BioNTech COVID-19 vaccine and our investigational protease inhibitor; and our expectations regarding the impact of COVID-19 on our business that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. 2020-11-16 Pfizer Inc. has concluded a deal to spin off its generic drugs unit Upjohn to merge with Mylan NV and form a new entity named Viatris Inc. The date for the Remove and Add actions would be the date of the spin-off. Should you have any questions about the Viatris spin-off, please do not hesitate to give us a call. Since Viatris is not part of our U.S. model and represents an extremely small portion of client portfolios, we will be selling the newly added Viatris shares to stay true to our equity models and to add to clients cash positions. Tax status of spinoff, enter 1 for tax-free, 2 for taxable, 3 for return of capital, 4 for mixed status, 12. Wealth advisory and brokerage services are provided by ScotiaMcLeod, a division of Scotia Capital Inc. International investment advisory services are provided by Scotia Capital Inc. Financial planning services are provided by The Bank of Nova Scotia and ScotiaMcLeod, a division of Scotia Capital Inc. Scotia Wealth Insurance Services Inc. is the insurance subsidiary of Scotia Capital Inc., a member of the Scotiabank group of companies. This Registration Statement on Form S-8 ("Registration Statement") registers 5,317,073 shares of common stock, par value $0.01 per share ("Common Stock"), of Viatris Inc. (the "Registrant") issuable to holders of Oyster Point Pharma, Inc. ("Oyster Point") stock options, restricted stock units and performance stock . Spinoff of Viatris (VTRS) from Pfizer (PFE) Pfizer spun off its Upjohn unit which immediately merged with Mylan to form Viatris, effective November 16, 2020 in a transaction meant to be tax-free to Pfizer shareholders. ". If tax status is return of capital or mixed, enter any return of capital per share of, 16. Spinoff - Merger. The sale grants Viatris $2 billion in upfront cash, $1 billion of convertible preferred equity representing a stake of at least 12.9% in Biocon Biologics and up to $335 million of additional payments. The news comes a few weeks after the merger was cleared in the U.S. after scoring approval in the EU, Australia and New Zealand. As per Business Wire's press release on November 16, "Upjohn Inc. was spun off to Pfizer stockholders by way of a pro rata distribution and immediately thereafter combined with Mylan. Please. it The combined company was renamed Viatris in connection with the closing. As a helpful service to our shareholders, Pfizer Inc. is making available the NetBasis Cost Basis system via a hyperlink on our Web site. "a Pfizer shareholder's pre-distribution tax basis in each Pfizer share should be allocated 94.8% to the Pfizer share and 5.2% to the Viatris share (including any Viatris fractional share) received with respect to the Pfizer share." More posts from r/stocks 5.2M subscribers _hiddenscout 7 days ago Intel Cuts Dividend by 66%. ", I'm a couple of updates behind and that "Corporate Securities Spin-off" is still there in my version. Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination Tuesday, November 12, 2019 - 07:15am . 1. Since EV to EBITDA does not include capital expenditures it is important to bring free cash flow to the table. After identifying the original security you acquired, you just need to enter the following information: Enter the date(s) for shares you acquired (purchased, inherited or received in a spin-off). The cost basis allocation information is calculated from the average of the opening and closing prices of VTRS and PFE on the effective date of the spinoff. I found I must make two entries to sort out the mess: one to remove the comingled fractional share then one to deposit the cash in lieu of the fractional share. I have no idea what Yahoo finance is doing. I have no business relationship with any company whose stock is mentioned in this article. assume the method is slightly different then when you buy shares. You will need to provide your personal purchase and sale history. and if that occurs then i have June 24, 2022 . Actually you can enter the price per share and Quicken will calculate the total cost, or you can enter the total cost and Quicken will calculate the price per share. If you have an ad-blocker enabled you may be blocked from proceeding. Broker reports one entry for whole shares and one cash-in-lieu of fractional share. In light of the distribution of the Upjohn business and its combination with Mylan to form Viatris, the Pfizer's 2020 financial guidance provided in its Q3 earnings release overstates expected total company results. Value investors love to do the opposite of the herd. "and to confuse me even more on yahoo finance they list stock prices The Viatris shares were only allocated a little over 5% of the original Pfizer cost and that suggests a Pfizer cost north of $200 per share. In addition, the stock is tremendously undervalued compared to peers. When discussing life insurance products, ScotiaMcLeod advisors are acting as Life Insurance Agents (Financial Security Advisors in Quebec) representing Scotia Wealth Insurance Services Inc. Scotia Capital Inc. is a member of the Canadian Investor Protection Fund and the Investment Industry Regulatory Organization of Canada. for every one share of Pfizer common stock held as of Nov. 13 and they retain the same number of Pfizer shares they held before the transaction. I tend to look for the aces. Press question mark to learn the rest of the keyboard shortcuts. endstream endobj 242 0 obj <>stream Disclosure: I/we have a beneficial long position in the shares of VTRS either through stock ownership, options, or other derivatives. price/share and Quicken calculates the cost.". Ever since, the stock has been underperforming due to selling pressure. Name of stock received in spinoff or enter your own data: 2. )SI{ 0BO|cEs}Oq""TV}c`u-hSwi8J", The company expects the "when-issued" market for Viatris common stock (VTRSV) to be available from Nov. 12 to Nov. 16, when it expects Upjohn to . Then enter the date(s) for the shares you sold. When will the Club Tax Printer software be available? Percent allocation of cost basis to new spinoff stock (for example, .2 for 20%), 7. Additionally, it frees up R&D, capital for reinvestments and share repurchases. Free cash flow remains strong to support shareholder returns and reinvestments. HS]O0}_qd_TILXv]@O.K{=p> X1R)MD*u 7p\y D2a\&bh1hq{.uNj`)9T@*pU&T!Bz $2ToWIGtfN.[4y7n1MDP0j=g*E^ X2SYJsOJ=I!J]D]KRihmOS-f&nR#wa{:f$f? Gaming. In consequence, the firm has much more room to reinvest in the business, pay down debt, pay out dividends and do share buybacks. $VTRS = (%VTRS / %PFE) * ($PFE / SR) OR $PFE = (%PFE / %VTRS) * SR * $VTRS End if Step 1, you will have five key values SR = 0.124079 $PFE = something in the $35 range (Although you may have to create the Add action through the Enter Transaction button to use total cost; I think it only works using cost per share if you enter directly in the transaction list. The spin off occurred in November 2020. If tax status is tax-free, enter 0.00, 13. Name of original stock he receive 37.2237 shares of Viatris based on the spinoff ratio of .124079. I have been active in the stock market since December 2020. If your broker does not use that guidance, the cost basis of the companies involved as recorded in your accounting records and in your brokers records will not match. I think your numbers look good in the overall. In addition you can try out all the features in our Trade Activities UI. Broker reports one entry for whole shares and one cash-in-lieu of fractional share. For a fee, you may use NetBasis to calculate the cost basis for your Pfizer Inc. common stock, adjusted for any corporate actions or dividend reinvestments. Pfizer has been advised by Nasdaq that a "when-issued" market for Viatris common stock will exist beginning on November 12, 2020, the date that is the business day immediately prior to the record date for the spin-off, and continuing until the close of business on the expected closing date of November 16, 2020. Viatris has by far the most attractive free cash flow yield and it is not even close. This cost-basis allocation is important for tracking the post-spinoff investment performance of each of the 2 companies, but it's also absolutely critical to having the correct costs for each individual lot of shares of the two companies for tax purposes (when one sells any of the shares.) To ensure this doesnt happen in the future, please enable Javascript and cookies in your browser. The forward-looking statements in the transcript speak only as of the original date of the webcast. Spinoff Calculator CALCULATOR FOR STOCK SPINOFFS Press the CTRL key simultaneously with the F5 key to refresh the calculator and make sure you are using the latest version before you enter any data. pfizer viatris spinoff cost basis. This release contains forward-looking information about the completion of the transaction which spun off Pfizer's Upjohn Business and combined it with Mylan N.V. to form Viatris Inc., as well as Pfizer's pipeline and actions to enhance shareholder value, including their potential benefits, that involves substantial risks and uncertainties that You must click the activation link in order to complete your subscription. Then enter the number of shares for every sale. So, its a pretty good 1:1 payback if you spend over there. The combined company was renamed "Viatris" in connection with the closing. Combine this with the dividend yield of almost 5% and the risk reward balance looks very favorable in these uncertain times. HQK0+.y+B")RaO m!n[d]{1|9s}Z2t6BIe)U$}C`u! To offset the decrease in growth by the biosimilar sale, the firm is also looking towards a gradual and diligent increase in R&D investments. If they do exist are they still manufactured by Pfizer or the Pfizer spin off Press J to jump to the feed. For the full year 2022, the company expects free cash flow to be between $2.5-$2.9 billion. The fund has been slightly outperforming the S&P 500 in the last 40 years with a 12.16% annual return. I am not receiving compensation for it (other than from Seeking Alpha). At Pfizer, we promise to treat your data with respect and will not share your information with any third party. Please check back for those steps at a later time. Currently, Viatris is highly leveraged compared to their free cash flow, nonetheless the firm is proactively decreasing debt. A description of these risks and uncertainties can be found in Pfizers most recent Annual Report on Form 10-K and in its subsequent reports on Form 10-Q, including in the sections thereof captioned Risk Factors and Forward-Looking Information and Factors That May Affect Future Results, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.govandwww.pfizer.com. Web site and will be redirected to the NetBasis system. Here is the information you need to complete the spinoff. Note: i'm taking over my dad's quicken duties due to age so i am new at using quicken. Unleashing the next wave of scientific innovations, Research and Business Development Partnerships. Netbasis contains all of the pricing and dividend history including all splits, mergers and Sympathy the whole Viatris thing was a mess, with Pfizer taking forever to release the cost basis information and even then not posting it in the proper place on their web site. How is VTRS cost basis calculated after the spinoff from PFE? Accordingly, the 4.8% dividend yield is relatively safe and already gives investors a great return on their investment. Netbasis will automatically calculate your adjusted cost basis for Company or any Company-affiliated company. Pfizer spun off its Upjohn unit which immediately merged with Mylan to form Viatris, effective November 16, 2020 in a transaction meant to be tax-free to Pfizer shareholders. Pfizer intends to provide its initial 2021 financial guidance in conjunction with its Q4 2020 earnings release. The transaction created a new entity, Viatris ( VTRS -0.26%),. It is structured to be a non-taxable event for Pfizer shareholders. .124079 and not one-to-one. NEW YORK-- ( BUSINESS WIRE )--Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc.. Looking at the high free cash flow yield and EV to EBTIDA ratio, few peers are even close to Viatris. For 2022, Viatris is on track to pay down $2 billion of debt. All you need to use NetBasis are your purchase/acquisition/sales dates and the number of shares acquired and/or sold on those dates. For double spins use same cost basis for both calculations. You can freely search securities along with their CUSIP, ticker, start and end date. The stock is now. Private banking services are provided by The Bank of Nova Scotia. share should be allocated 94.8% to the Pfizer share and 5.2% to the Viatris share (including any Viatris fractional share) received with respect to the Pfizer share. were obligated to sell their shares since Viatris is a mid cap stock. "i'm running version R32.10 and from what i understand there use to be a You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. if you multiply your back-of-the-envelope Why don't my current members have K-1 forms? Cash received in lieu of fractional shares (often denoted as CIL) (enter 0.00 if none), 11. Regarding Viatris spinoff from Pfizer Fred Glock Member January 2021 Download has two partial entries with different prices and ends with two sets of fractional shares. Even so, one time costs from the merger are coming down, SG&A expense are decreasing and synergies between the two companies could perhaps increase free cash flow. Please disable your ad-blocker and refresh. This transcript may contain forward-looking statements about, among other things, our anticipated operating and financial performance, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, post-approval clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; manufacturing and product supply; our efforts to respond to COVID-19, including our development of a vaccine to help prevent COVID-19 and our investigational protease inhibitor; our expectations regarding the impact of COVID-19 on our business; plans for and prospects of our acquisitions, dispositions and other business-development activities, and our ability to successfully capitalize on these opportunities; and discussions relating to strategic reviews, capital allocation objectives, dividends and share repurchases, among other things, that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional disclosure: I am not a financial advisor. Do they still exist? "for the Viatris data and using the cost basis calculator from the web Earlier this week, the vaccines success rate increased to 95%, which leaves investors excited and the healthcare industry hopeful that a vaccine is just around the corner. In the distribution, Pfizer stockholders received approximately 0.124079 shares . r/benzodiazepines. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Click Yes if you reinvested dividends for the entire holding period or enter the start or end dates. Chris Davis, a known value investor, has been growing his Viatris position towards a 3-3.5% weighting in the Davis New York Venture Fund. result of the spin-off by Pfizer Inc. ("Pfizer") of its global, primarily off-patent branded and generic established medicines business (the "Upjohn Business") and, immediately thereafter, the combination of the Upjohn Business with Mylan N.V. ("Mylan"). 4+t?1zxn nmZn5&xUAX5N(;a,r}=YUUA?z r[ $ In the Transaction List for the Account click the "Enter Transactions" button in the upper left hand corner and you'll find it. This publication has been prepared by Scotia Capital Inc. and is intended as a general source of information only and should not be considered as personal and/or specific financial, tax, pension, legal or investment advice. 275 0 obj <>/Filter/FlateDecode/ID[<24841444BF501D43904D036F3693E702><07E66463EA475B4CBF3DD01F72C540F1>]/Index[238 109]/Info 237 0 R/Length 142/Prev 413857/Root 239 0 R/Size 347/Type/XRef/W[1 2 1]>>stream Can we free up the capital? Log In Sign Up. Pfizer spun off part of their business to form Viatris.". Tax will still be a mess, but for another day. Spinoff ratio (for example .5 in a 1 for 2 spinoff), 6. In the graphs below, I have compared competitors and peers of Viatris in terms of EV to EBITDA and free cash flow yield. NOTE: As of 11/20/20, these steps are only for Pfizer Shareholders. The date for the Remove and Add actions would be the date of the spin-off. You can sign up for additional alert options at any time. User account menu. as investors are still clueless about what to do. If you are unfamiliar with spinoff transactions you can get help at this URL: https://www.iclub.com/support/kb/default.asp?page=normal_spinoff. Registered trademark of The Bank of Nova Scotia, used under licence. Safe and high dividend yield combined with exceptional free cash flow yield offer a great margin of safety. I think you have something wrong here. Experience the future in cost basis reporting & analysis. Pfizer (NYSE: PFE) expects common stock for its Viatris spin-off to be available starting Nov. 12, following the U.S. Federal Trade Commission's approval of the proposed merger of Mylan (NSDQ: MYL) and Pfizer's biopharmaceutical Upjohn brand.. This publication may not be reproduced in whole or in part without the prior express consent of Scotia Capital Inc. Scotiabank digital banking provides you with secure and convenient access to your accounts and investments via theinternet. Spin-offs of this nature are one of the multiple benefits of investing in large companies that grow their businesses at scale. Enter the number of shares for every acquisition. Where do the Form 1065, schedule D, and K-1 entries come from in Club Accounting? My cost basis is $17.11 for VTRS and I was wondering how was it calculated? Welcome to my journey!Achieved 4th place in the student investing competition of the financial newspaper DeTijd. Name of tax information statement if available. We view this announcement as a positive development that allows Pfizer to focus on core operations while adding value to current shareholders, and more importantly, our clients. I wouldn't use it though as I don't believe that a bug in that action - a. I am here to give you insights on my investment portfolio and how I manage to decide whether I should invest in a particular stock or not. In our experience brokers tend to use the prices found in the guidance companies post on their websites including IRS form 8937. Financial metrics are positively increasing as one-time costs of the merger are decreasing. with accounting principles generally accepted in the United States of America and related standards or on an adjusted basis; the integration of Mylan and Newco being more difficult, time consuming or costly . This is not cause for concern. invest with a margin of safety should consider Viatris as it offers an attractive dividend yield of 4.8%. Pfizer spun off its Upjohn unit which immediately merged with Mylan to form Viatris, effective November 16, 2020 in a transaction meant to be tax-free to Pfizer shareholders. This information can often be found on several types of investment documents including: broker If you have an ad-blocker enabled you may be blocked from proceeding. 7878 North 16th Street, Suite 175 Phoenix, AZ 85020, The information and documentation needed to, A historical reconstruction of your investment including all. Investing is your own responsibility. I rate Viatris a Strong Buy below $10 per share. Of course you understand that if you're entering the 300 shares as 3 different lots, because that's the real situation, each lot will have unique number of shares and "per share" cost numbers. Tagged: Investments for Viatris going back to 4/13/2020. Please disable your ad-blocker and refresh. Opinions and projections contained in this publication are our own as of the date hereof and are subject to change without notice. When a company goes through a reorganization such as a split, a spinoff or a merger, your cost basis in your shares needs to be adjusted. Get directions Total cost of original stock purchase, including commissions and fees, adjusted for previous spinoffs and return of capital payments. For a fee, you may use NetBasis to calculate the cost basis for your Pfizer Inc. common stock, adjusted for any corporate actions or dividend reinvestments. 16/11/20. "ChpEObbG]!>E5o(fV+. You're right. endstream endobj 241 0 obj <>stream At this stage, I'll take the fractional shares left from the total at the value for the total and enter it as cash received. But let's not forget this company had a recent merger. 238 0 obj <> endobj %%EOF announced a sale of their biosimilars portfolio to Biocon Biologics, Goldman Sachs 43rd annual global healthcare conference. NEW YORK - November 16, 2020 - Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc. Pfizer Chairman and Chief Executive Officer Dr. Albert Bourla said, "We are proud to have completed the combination of Upjohn and Mylan . In the beginning of 2022, Viatris announced a sale of their biosimilars portfolio to Biocon Biologics. In my taxable Fidelity account, they show my basis in Pfizer going down by $1.72 per share (in my case, from $33.08 to $31.36. Viatris Market Cap Today's Change Current Price $11.69 Price as of February 17, 2023, 4:00 p.m. Number of shares of original stock, adjusted for splits since purchase. Scotia OnLine. Consequently, the selling pressure started hammering down the stock once Viatris started trading on the Nasdaq. The expected spending increase on R&D should also be favorable for the company as the CEO mentioned at the conference: If you have tracked us for the last four or five years or six years, thats what we have been spending, $600 million, $700 million in R&D and we have been getting $600 million, $700 million in annual launches. Two things have to be correct: 1) Total basis immediately after the spin off is the same as total basis immediately before the spin off and 2) the allocation of basis between Pfizer and Viatris is defensible. i was under the impression that Cost Basis of Transferred Securities in a withdrawal. How can I tell if a dividend is qualified or not? Accurate pricing and corporate actions for your securities. More so, the firm is considering a buyback program after the biosimilars asset sale. My mental math completely failed me here because I forgot to factor in the spin off ratio. I am not accountable for any of your losses. Anything near 95%/5% is undoubtedly OK. "But having said that, that cost per share of $11.64 does seem awfully high. Root Vegetable Hash with Poached Eggs and Parsley Pesto, Pork With Fried Rice and Vegetable Casserole, Baba Gannoujh Middle Eastern Eggplant Spread. Percent allocation of cost basis to original stock (for example .8 for 80%), 8. Hi everyone, I'm 22 years old and studying electromechanics in college. Download has two partial entries with different prices and ends with two sets of fractional shares. Investors that invest with a margin of safety should consider Viatris as it offers an attractive dividend yield of 4.8%. Although the assets were sold at 16,5 times EBITDA, investors took the news extremely negative as this could potentially destroy the growth for the company. If tax status is taxable or mixed, enter market value per share on date of distribution of spinoff stock received. Save the transaction and the spinoff has been entered. This results into a 23% payout ratio of free cash flow for the bear case, giving the firm plenty of room to payback debt and reinvest into the business. If you do want to do the spin-off manually then a Remove action for Pfizer would eliminate all Pfizer lots. Being leveraged can amplify returns on investments and increase buying power, but too much leverage can create risky environments. using the cost basis web site i mentioned in the original post shows that the Pfizer cost basis is $7897.79 and the Viatris cost basis is $433.21.
How To Remove Nexcare Waterproof Bandages,
Biggest Drug Bust In New Orleans,
John Clay Wolfe Net Worth,
Vagrancy Is A Crime Against Property,
Articles P
